indian short bowel syndrome market

Indian Short Bowel Syndrome Market: Segmented By Drug Class (Glucagon-like Peptide, Anti-Diarrheal, Histamines Blockers, Proton Pump Inhibitors, Growth Hormone), By Mode Drug of Administration (Oral Administration, Parental Administration) - Growth, Trends, and Forecasts (2019 2028)

  • Published Date: 2022-12-28
  • Report ID: 139655
  • Pages: 200
  • Format: prudent report format

Report Overview

Indian Short Bowel Syndrome market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

The Short Bowel Syndrome Market growth rate is expected to increase the public awareness about the generic disorders or bowel related disorders is influencing the vendors and authorities to provide adequate knowledge. Short bowel syndrome is a group of problems related to poor absorption of nutrients. Short bowel syndrome typically occurs in people who have had at least half of their small intestine removed and sometimes all or part of their large intestine removed, significant damage of the small intestine, poor motility, or movement, inside the intestines. The main symptom of short bowel syndrome is diarrhealoose, watery stools, which can lead to dehydration, malnutrition, and weight loss. From the initiates by many government bodies, pharmaceutical companies, health ministries, and NGOs conduct health programs and camps to educate the people and raise awareness to the market players distributing free samples and kits with the aim of educating the people and promoting their drugs is anticipated to propel the Short Bowel Syndrome Market during the forecast period 2019-2028.



Market Drivers

The major factors attributing to the growth of the SBS market are rise in Indian prevalence of GI disorders like volvulus, Inflammatory bowel disease (IBD), in particular, Crohns disease (CD), which predisposes patients to development of SBS and mesenteric ischemia are the most common causes for SBS among all the age groups which demand the necessity of the treatment.Additionally, the increased awareness programs led by several associations like the Association of gastrointestinal motility, Oley Foundation and the SBS Cure Project coupled with rising in the government health care expenditure are likely to drive the market growth over the forecast period. Rising awareness and availability of epidemiological data lead to the better management of short bowel disease. Further, rapid improvements in the field of healthcare have increased awareness regarding short bowel syndrome and thus, created opportunities. Along with these, non-profit organizations are promoting research & development around short bowel syndrome in joint scientific research between the public sector and the private sector.


1. Indian Short Bowel Syndrome Market Overview...........................
A. Market Size
2. Market Growth Drivers.
A. Rising Awareness and Availability of Epidemiological Data
B. Prevalence of GI Disorders like Volvulus, Inflammatory Bowel Disease (IBD)
3. Major Short Bowel Syndrome Treatment types
A. Nutritional Therapy
B. Medications
C. Surgery
4. Short Bowel Syndrome Market Segmentation...................
A. By Drug Class
I. Glucagon-like Peptide
II. Anti-Diarrheal
III. Histamines Blockers
IV. Proton Pump Inhibitors
V. Growth Hormone
B. By Mode of Administration
I. Oral Administration
II. Parental Administration
5. Short Bowel Syndrome Major Products Market Share.
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape......
A. Major Players
B. Products in Pipeline
7. Key Company Profiles.
A. Ardelyx Inc. Company, overview, Product & Services, Strategies & Financials
B. Emmaus Life Sciences Inc. Company, overview, Product & Services, Strategies & Financials
C. GLyPharma Therapeutics Inc. Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Development of Short Bowel Syndrome Market
B. Future Opportunities
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.